| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 75.47▲ | 75.47▲ | 75.44▲ | 75.41▲ | 76.05▼ |
| MA10 | 75.44▲ | 75.44▲ | 75.43▲ | 75.46▲ | 76.34▼ |
| MA20 | 75.41▲ | 75.39▲ | 75.39▲ | 75.94▼ | 76.44▼ |
| MA50 | 75.41▲ | 75.46▲ | 75.68▼ | 76.41▼ | 76.47▼ |
| MA100 | 75.81▼ | 76.05▼ | 76.20▼ | 76.48▼ | N/A |
| MA200 | 76.24▼ | 76.34▼ | 76.36▼ | 76.45▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.022▲ | 0.033▲ | 0.042▲ | -0.033▼ | -0.138▼ |
| RSI | 69.196▲ | 63.526▲ | 58.088▲ | 39.211▼ | 40.565▼ |
| STOCH | 54.762 | 54.762 | 45.757 | 23.369 | 32.881 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -83.236▼ | -85.922▼ |
| CCI | 191.228▲ | 185.914▲ | 185.648▲ | -27.017 | -195.150▼ |
|
Tuesday, May 06, 2025 11:10 PM
Arbutus Biopharma Corporation announced promising data from a late-breaker poster presentation at the EASL Congress 2025, revealing that its treatment combining imdusiran, a RNAi therapeutic, with VTP ...
|
|
Friday, November 12, 2021 05:00 AM
Interim data from two studies, HBV001 and HBV002, showed that in chronic Hepatitis B (CHB) patients the heterologous prime-boost vector combination, ChAdOx1-HBV + MVA-HBV (VTP-300), induced robust T ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/07/26 | 75.52 | 75.62 | 75.505 | 75.53 | 27,007 |
| 16/07/26 | 75.34 | 75.40 | 75.32 | 75.36 | 10,199 |
| 15/07/26 | 75.35 | 75.50 | 75.35 | 75.42 | 26,751 |
| 14/07/26 | 75.35 | 75.425 | 75.285 | 75.385 | 30,315 |
| 13/07/26 | 75.41 | 75.41 | 75.24 | 75.33 | 29,820 |
| 10/07/26 | 75.44 | 75.48 | 75.41 | 75.48 | 34,106 |
| 09/07/26 | 75.445 | 75.515 | 75.44 | 75.46 | 52,518 |
| 08/07/26 | 75.45 | 75.475 | 75.37 | 75.44 | 104,427 |
| 07/07/26 | 75.61 | 75.62 | 75.45 | 75.49 | 48,303 |
| 06/07/26 | 75.64 | 75.71 | 75.57 | 75.71 | 27,472 |
|
|
||||
|
|
||||
|
|